- Home
- BWA vs RGC Comparison
BWA vs RGC Comparison
Compare BWA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BWA | RGC |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 11.5B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BWA | RGC |
|---|---|---|
| Price | $67.53 | $6.24 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $59.33 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 165.3K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $14,316,000,000.00 | N/A |
| Revenue This Year | $1.54 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $59.73 | ★ N/A |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $33.14 | $7.17 |
| 52 Week High | $78.82 | $69.00 |
Technical Indicators
Market Signals| Indicator | BWA | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 14.88 |
| Support Level | $52.03 | N/A |
| Resistance Level | $70.19 | $16.97 |
| Average True Range (ATR) | 2.79 | 2.33 |
| MACD | -1.16 | -1.08 |
| Stochastic Oscillator | 6.04 | 2.97 |
Price Performance
Historical ComparisonAbout BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.